参考文献/References:
[1]Bluher M.Obesity: global epidemiology and pathogenesis [J].Nat Rev Endocrinol,2019,15(5):288-298.[2]Jia WP,Liu F.Obesity: causes, consequences, treatments, and challenges [J].J Mol Cell Biol,2021,13(7):463-465.[3]Lin X,Li H.Obesity: Epidemiology, Pathophysiology, and Therapeutics [J].Front Endocrinol (Lausanne),2021,12(7):69-78.[4]Saxton SN,Clark BJ,Withers SB,et al.Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue [J].Physiol Rev,2019,99(4):1701-1763.[5]Eckel N,Li Y,Kuxhaus O,et al.Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study [J].Lancet Diabetes Endocrinol,2018,6(9):714-724.[6]Mongraw-Chaffin M,Foster MC,Anderson CAM,et al.Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk [J].J Am Coll Cardiol,2018,71(17):1857-1865.[7]Smith GI,Mittendorfer B,Klein S.Metabolically healthy obesity:facts and fantasies [J].J Clin Invest,2019,129(10):3978-3989.[8]Bluher M.Metabolically Healthy Obesity[J].Endocr Rev,2020,41(3):bnaa004.[9]Van Vliet-Ostaptchouk JV,Nuotio ML,Slagter SN,et al.The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies[J].BMC Endocr Disord,2014,14:9.[10]Lavie CJ,Laddu D,Arena R,et al.Healthy Weight and Obesity Prevention: JACC Health Promotion Series [J].J Am Coll Cardiol,2018,72(13):1506-1531.[11]Magkos F.Metabolically healthy obesity: what’s in a name? [J].Am J Clin Nutr,2019,110(3):533-539.[12]Gomez-Zorita S,Queralt M,Vicente MA,et al.Metabolically healthy obesity and metabolically obese normal weight: a review [J].J Physiol Biochem,2021,77(1):175-189.[13]Eckel N,Meidtner K,Kalle-Uhlmann T,et al.Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis [J].Eur J Prev Cardiol,2016,23(9):956-966.[14]Rey-Lopez JP,De Rezende LF,Pastor-Valero M,et al.The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used [J].Obes Rev,2014,15(10):781-790.[15]Liu C,Wang C,Guan S,et al.The Prevalence of Metabolically Healthy and Unhealthy Obesity according to Different Criteria [J].Obes Facts,2019,12(1):78-90.[16]Lin H,Zhang L,Zheng R,et al.The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article [J].Medicine (Baltimore),2017,96(47):e8838.[17]Goossens GH.The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function [J].Obes Facts,2017,10(3):207-215.[18]Soriguer F,Gutierrez-Repiso C,Rubio-Martin E,et al.Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study [J].J Clin Endocrinol Metab,2013,98(6):2318-2325.[19]Appleton SL,Seaborn CJ,Visvanathan R,et al.Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study [J].Diabetes Care,2013,36(8):2388-2394.[20]Bray GA,Kim KK,Wilding JPH,et al.Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation [J].Obes Rev,2017,18(7):715-723.[21]Ghiassi S,El Chaar M,Aleassa EM,et al.ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgery [J].Surg Obes Relat Dis,2020,16(6):713-724.[22]Mili N,Paschou SA,Goulis DG,et al.Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations [J].Endocrine,2021,74(3):478-497.[23]Neeland IJ,Ross R,Despres JP,et al.Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement [J].Lancet Diabetes Endocrinol,2019,7(9):715-725.